GHK-Cu Research: What the Literature Supports

Cover illustration: AI-generated editorial artwork. Conceptual only; not an exact molecular structure, actual laboratory result or evidence of clinical effects.

GHK-Cu has an unusual evidence profile. There is a solid primary study from 1993 in a major journal, a large volume of review literature concentrated in the hands of one author, and a recent wave of formulation papers. Reading these as a single undifferentiated body of evidence overstates what is established; reading them separately is more informative. This is an attempt at the latter.

For laboratory research use only. The research materials supplied by HealthyWelness are not approved medicines, foods or cosmetics and are not for human or veterinary use. This article summarises published research and is not medical advice.

The three layers of the literature

Layer	Representative work	Evidential weight
Primary in vivo	Maquart 1993, J Clin Invest	Strong for its specific claim
Review and synthesis	Pickart 2008, 2014	Useful orientation; concentrated authorship
Formulation and delivery	2025–2026 reviews and materials work	Most useful for handling questions

The 1993 study, and what it actually showed

The paper by Maquart and colleagues in the Journal of Clinical Investigation is the foundation of the field. It reported in vivo stimulation of connective tissue accumulation by the glycyl-L-histidyl-L-lysine–Cu²⁺ complex in rat experimental wounds.

Two things are worth noting about it. First, it is a primary in vivo study in a high-impact journal from an independent group, which is more than can be said for most of the research-peptide literature. Second, its claim is specific: connective tissue accumulation, in a rat wound model, with the copper complex. It is not a general claim about tissue regeneration, and it does not establish anything about intact skin, about other tissues, or about outcomes in humans.

When a later source cites this paper in support of a broader claim, the gap between the paper’s finding and the claim being made is where the reader has to apply judgement.

The review literature and the authorship question

A notable feature of the GHK field is that one researcher, Loren Pickart, authored a large share of its review literature across several decades. The 2008 review in the Journal of Biomaterials Science, Polymer Edition on GHK and tissue remodelling is a representative example and a reasonable orientation to the topic.

This is not an accusation of anything. Fields often have a founding figure, and long engagement produces genuine expertise. But it does change how the volume of citations should be read. Twenty papers from one group are not twenty independent confirmations. When assessing how well-established a claim is, the relevant question is how many independent groups have tested it, and for several GHK claims the answer is few.

The 2014 paper in BioMed Research International, titled “GHK and DNA: resetting the human genome to health”, is the most expansive of these. Its claims about gene expression rest largely on the interpretation of transcriptome datasets rather than on targeted functional experiments. Transcriptome-level correlations are a legitimate starting point for hypotheses; they are not a demonstration of mechanism, and the title’s framing is considerably stronger than the underlying method supports.

The copper problem

This is the most interesting unresolved question in the field, and it receives surprisingly little direct attention. GHK-Cu delivers copper. Copper is biologically active in its own right, participating in redox chemistry and serving as a cofactor for enzymes involved in connective tissue cross-linking.

So when an effect is observed with GHK-Cu, how much is attributable to the peptide as a signalling entity, and how much to copper delivered in a bioavailable form? Answering that requires controls that are rarely reported:

Copper salt alone, at matched copper concentration.
The apo-peptide, GHK without copper.
A comparable copper chelate that is not GHK.

Without that set, an experiment measures the complex, not the peptide. This is a real design consideration rather than a pedantic one, and it is the first thing we would check in any new GHK-Cu study.

What the recent work adds

The newer literature has shifted towards chemistry and delivery, which is where it is most useful. The 2025 review by Adnan and colleagues in the International Journal of Medical Sciences places GHK among tripeptides in wound healing and skin regeneration generally — a comparative framing that makes it easier to see what is specific to GHK and what is common to small peptides in this context.

Work published in 2026 in Pharmaceutics addresses GHK-Cu explicitly as a metallopeptide, covering coordination chemistry and formulation science. For laboratory handling this is the most directly relevant recent material, because the coordination chemistry determines how the complex behaves on dissolution, at different pH values, and in the presence of competing chelators.

Handling consequences

The copper coordination is not incidental to handling.

Competing chelators displace copper. EDTA and similar additives in a buffer will strip the complex. Check buffer composition before assuming the complex is intact in solution.
pH affects coordination. The histidine imidazole is part of the copper binding, and its protonation state is pH-dependent.
Colour is a crude but real indicator. Copper complexes of this kind are visibly coloured; a solution that has lost its colour has lost something.
Store sealed lyophilized material at −20 °C, dry and dark; aliquot after reconstitution. See GHK-Cu handling.
Concentration maths should use the complex’s molecular weight, not the free tripeptide’s. Our reconstitution calculator takes molecular weight as an explicit input.

Our GHK-Cu research material is supplied for laboratory research use. Certificates are available for listed products — contact us for the latest report.

Where this leaves the evidence

A fair summary: one well-regarded primary in vivo study supports a specific claim about connective tissue in a rodent wound model. A large review literature, concentrated in one group’s authorship, proposes considerably more than that. Recent chemistry and formulation work is the most reliable guide to how the material behaves. The peptide-versus-copper question remains open and is answerable with existing methods.

Open questions

How much of GHK-Cu’s activity survives substitution of a different copper chelate?
Have the gene-expression claims been tested by independent groups with functional readouts?
How stable is the copper coordination in common laboratory buffers?

Frequently asked questions

What is the strongest primary evidence on GHK-Cu?

The 1993 Journal of Clinical Investigation paper by Maquart and colleagues, which reported stimulation of connective tissue accumulation by the tripeptide-copper complex in rat experimental wounds. It is a primary in vivo study in a high-profile journal and remains the most frequently cited foundation for the field.

Who is Loren Pickart and why does his name appear so often?

Pickart is the researcher most associated with GHK, having worked on it since the 1970s and authored a large proportion of the review literature. That concentration of authorship is worth noting when assessing how independent the body of evidence is.

Does GHK-Cu alter gene expression?

A 2014 review proposed broad effects on gene expression. Those claims rest largely on transcriptome analyses and their interpretation rather than on targeted functional experiments, so they are best read as hypotheses about mechanism rather than established findings.

Is the copper essential to the activity?

The complex is defined by the copper, and the coordination chemistry is central to how the molecule is described. Separating the contribution of the peptide from that of delivered copper is one of the genuine open questions in the field.

What is the recent literature adding?

Mostly formulation and delivery work, plus systematic reviews. A 2026 Pharmaceutics paper addresses coordination chemistry and formulation science specifically, which is the kind of material most useful for laboratory handling.

References

Maquart FX, et al. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. J Clin Invest. 1993. PMID: 8227353 https://pubmed.ncbi.nlm.nih.gov/8227353/
Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008. PMID: 18644225 https://pubmed.ncbi.nlm.nih.gov/18644225/
Pickart L, et al. GHK and DNA: resetting the human genome to health. Biomed Res Int. 2014. PMID: 25302294 https://pubmed.ncbi.nlm.nih.gov/25302294/
Adnan SB, et al. Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review. Int J Med Sci. 2025. PMID: 41209547 https://pubmed.ncbi.nlm.nih.gov/41209547/